Peyton R. Howell's most recent trade in Tandem Diabetes Care Inc was a trade of 8,759 Restricted Stock Unit done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 8,759 | 8,759 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.64 per share. | 21 May 2025 | 4,387 | 21,077 (0%) | 0% | 20.6 | 90,548 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 4,387 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.73 per share. | 22 May 2024 | 4,434 | 16,690 (0%) | 0% | 51.7 | 229,371 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 4,434 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,387 | 4,387 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 949 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 949 | 12,256 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 4,434 | 4,434 | - | - | RSU 2023 05 24 | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 11,307 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 30.16 per share. | 17 May 2023 | 3,000 | 8,550 (0%) | 0% | 30.2 | 90,492 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 949 | 5,550 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 949 | 949 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 1,653 | 4,601 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 1,653 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 75.00 per share. | 06 May 2022 | 500 | 2,465 (0%) | 0% | 75 | 37,500 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 74.60 per share. | 06 May 2022 | 500 | 1,565 (0%) | 0% | 74.6 | 37,300 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 74.58 per share. | 06 May 2022 | 483 | 2,948 (0%) | 0% | 74.6 | 36,022 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 75.21 per share. | 06 May 2022 | 400 | 1,965 (0%) | 0% | 75.2 | 30,084 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 75.21 per share. | 06 May 2022 | 100 | 1,048 (0%) | 0% | 75.2 | 7,521 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Purchase of securities on an exchange or from another person at price $ 74.59 per share. | 06 May 2022 | 17 | 1,065 (0%) | 0% | 74.6 | 1,268 | Common Stock |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 948 | 948 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 948 | 1,898 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Peyton R. Howell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,653 | 1,653 | - | - | Restricted Stock Unit |